Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3334867rdf:typepubmed:Citationlld:pubmed
pubmed-article:3334867lifeskim:mentionsumls-concept:C0008377lld:lifeskim
pubmed-article:3334867lifeskim:mentionsumls-concept:C0242216lld:lifeskim
pubmed-article:3334867lifeskim:mentionsumls-concept:C0026682lld:lifeskim
pubmed-article:3334867lifeskim:mentionsumls-concept:C0015688lld:lifeskim
pubmed-article:3334867lifeskim:mentionsumls-concept:C0234402lld:lifeskim
pubmed-article:3334867pubmed:issue1lld:pubmed
pubmed-article:3334867pubmed:dateCreated1988-2-25lld:pubmed
pubmed-article:3334867pubmed:abstractTextThe concentration of free fatty acids, phosphatidylcholine and lysophosphatidylcholine, and the fatty acid composition as well as the levels of the mucins, analyzed by an improved GLC method, were examined in ten biles from patients with cholesterol gallstones (pathological biles) and in ten control biles. In pathological biles the amounts of free fatty acids and phosphatidylcholine, were significantly higher (8.99 +/- 1.09) vs. 2.75 +/- 0.62 micrograms/mg) and lower (6.62 +/- 0.71 vs. 21.91 +/- 3.86 micrograms/mg), respectively, than in control biles, indicating that a relationship exists between the two lipid fractions. Lysophosphatidylcholine concentrations remained unchanged in the two groups (1.02 +/- 0.55 micrograms/mg in pathological biles vs. 1.32 +/- 0.57 micrograms/mg in control biles). The increased levels of free fatty acids were directly correlated (r = 0.73, P less than 0.05) with biliary hypersecretion of mucus glycoproteins. Acetylglucosamine and acetylgalactosamine were significantly higher in pathological biles than in control biles (1.91 +/- 0.67 vs. 0.60 +/- 0.13 microgram/mg). The nucleating potency of the increased amounts of mucins, coupled with lowered levels of phosphatidylcholine, might play a very important role in stone formation and precipitation.lld:pubmed
pubmed-article:3334867pubmed:languageenglld:pubmed
pubmed-article:3334867pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3334867pubmed:citationSubsetIMlld:pubmed
pubmed-article:3334867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3334867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3334867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3334867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3334867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3334867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3334867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3334867pubmed:statusMEDLINElld:pubmed
pubmed-article:3334867pubmed:monthJanlld:pubmed
pubmed-article:3334867pubmed:issn0006-3002lld:pubmed
pubmed-article:3334867pubmed:authorpubmed-author:GrecoA VAVlld:pubmed
pubmed-article:3334867pubmed:authorpubmed-author:MingroneGGlld:pubmed
pubmed-article:3334867pubmed:authorpubmed-author:PassiSSlld:pubmed
pubmed-article:3334867pubmed:authorpubmed-author:FinottiEElld:pubmed
pubmed-article:3334867pubmed:issnTypePrintlld:pubmed
pubmed-article:3334867pubmed:day19lld:pubmed
pubmed-article:3334867pubmed:volume958lld:pubmed
pubmed-article:3334867pubmed:ownerNLMlld:pubmed
pubmed-article:3334867pubmed:authorsCompleteYlld:pubmed
pubmed-article:3334867pubmed:pagination52-9lld:pubmed
pubmed-article:3334867pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:meshHeadingpubmed-meshheading:3334867-...lld:pubmed
pubmed-article:3334867pubmed:year1988lld:pubmed
pubmed-article:3334867pubmed:articleTitleFree fatty acids: a stimulus for mucin hypersecretion in cholesterol gallstone biles.lld:pubmed
pubmed-article:3334867pubmed:affiliationIstituto di Clinica Medica, Catholic University, Rome, Italy.lld:pubmed
pubmed-article:3334867pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3334867pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3334867pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3334867lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3334867lld:pubmed